Food and Drug Administration (FDA) Commissioner Robert Califf said on Jan. 31 that major reforms will be coming to his agency in the wake of the recent infant formula shortages. ...
The U.S. Food and Drug Administration's (FDA) approval process of the controversial and costly new Alzheimer’s drug Aduhelm was "rife with irregularities" ...